168 related articles for article (PubMed ID: 19749756)
1. Interferon-alfa, interferon-lambda and hepatitis C.
O'Brien TR
Nat Genet; 2009 Oct; 41(10):1048-50. PubMed ID: 19749756
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.
Susser S; Herrmann E; Lange C; Hamdi N; Müller T; Berg T; Perner D; Zeuzem S; Sarrazin C
PLoS One; 2014; 9(11):e112592. PubMed ID: 25393304
[TBL] [Abstract][Full Text] [Related]
3. IL28B: A new wager in the skyline of hepatitis C virus infection.
Mangia A
Dig Liver Dis; 2011 Mar; 43(3):177-9. PubMed ID: 21237729
[No Abstract] [Full Text] [Related]
4. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
Suppiah V; Moldovan M; Ahlenstiel G; Berg T; Weltman M; Abate ML; Bassendine M; Spengler U; Dore GJ; Powell E; Riordan S; Sheridan D; Smedile A; Fragomeli V; Müller T; Bahlo M; Stewart GJ; Booth DR; George J
Nat Genet; 2009 Oct; 41(10):1100-4. PubMed ID: 19749758
[TBL] [Abstract][Full Text] [Related]
5. Genetic factors and hepatitis C virus infection.
Thompson AJ
Gastroenterology; 2012 May; 142(6):1335-9. PubMed ID: 22537440
[No Abstract] [Full Text] [Related]
6. Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients.
Zhang YY; Chen HB; Xu Y; Huang P; Wang J; Zhang Y; Yu RB; Su J
World J Gastroenterol; 2015 Apr; 21(13):4006-13. PubMed ID: 25852288
[TBL] [Abstract][Full Text] [Related]
7. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
[TBL] [Abstract][Full Text] [Related]
8. Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1.
Oze T; Hiramatsu N; Yakushijin T; Miyazaki M; Iio S; Oshita M; Hagiwara H; Mita E; Inui Y; Hijioka T; Inada M; Tamura S; Yoshihara H; Inoue A; Imai Y; Miyagi T; Yoshida Y; Tatsumi T; Kanto T; Kasahara A; Hayashi N; Takehara T
J Gastroenterol; 2014 Apr; 49(4):737-47. PubMed ID: 23689988
[TBL] [Abstract][Full Text] [Related]
9. Comment on: 'interleukin-28 polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis'.
Fernández-Rodríguez A; Jiménez-Sousa MÁ; Resino S
Gene; 2013 Jun; 522(1):121. PubMed ID: 23506831
[No Abstract] [Full Text] [Related]
10. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y
World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
Tanaka Y; Nishida N; Sugiyama M; Kurosaki M; Matsuura K; Sakamoto N; Nakagawa M; Korenaga M; Hino K; Hige S; Ito Y; Mita E; Tanaka E; Mochida S; Murawaki Y; Honda M; Sakai A; Hiasa Y; Nishiguchi S; Koike A; Sakaida I; Imamura M; Ito K; Yano K; Masaki N; Sugauchi F; Izumi N; Tokunaga K; Mizokami M
Nat Genet; 2009 Oct; 41(10):1105-9. PubMed ID: 19749757
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
Hayashi K; Katano Y; Kuzuya T; Tachi Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Urano F; Yoshioka K; Toyoda H; Kumada T; Goto H
J Med Virol; 2012 Mar; 84(3):438-44. PubMed ID: 22246829
[TBL] [Abstract][Full Text] [Related]
13. Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.
Hayashi K; Katano Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
Liver Int; 2011 Oct; 31(9):1359-65. PubMed ID: 21745312
[TBL] [Abstract][Full Text] [Related]
14. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
Rallón NI; Soriano V; Naggie S; Restrepo C; Goldstein D; Vispo E; McHutchison J; Benito JM
AIDS; 2011 May; 25(8):1025-33. PubMed ID: 21505315
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.
Shi KQ; Liu WY; Lin XF; Fan YC; Chen YP; Zheng MH
Gene; 2012 Oct; 507(1):27-35. PubMed ID: 22842190
[TBL] [Abstract][Full Text] [Related]
16. Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype.
Han H; Noureddin M; Witthaus M; Park YJ; Hoofnagle JH; Liang TJ; Rotman Y
J Hepatol; 2013 Nov; 59(5):957-63. PubMed ID: 23850879
[TBL] [Abstract][Full Text] [Related]
17. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
Itokawa N; Atsukawa M; Tsubota A; Kondo C; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Iwakiri K; Sakamoto C
J Gastroenterol Hepatol; 2013 Mar; 28(3):443-9. PubMed ID: 23173698
[TBL] [Abstract][Full Text] [Related]
18. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients.
Haj-Sheykholeslami A; Keshvari M; Sharafi H; Pouryasin A; Hemmati K; Mohammadzadehparjikolaei F
World J Gastroenterol; 2015 Aug; 21(29):8935-42. PubMed ID: 26269684
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
Flisiak R; Shiffman M; Arenas J; Cheinquer H; Nikitin I; Dong Y; Rana K; Srinivasan S
PLoS One; 2016; 11(10):e0164563. PubMed ID: 27749900
[TBL] [Abstract][Full Text] [Related]
20. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
